BioFactura and CuraTeQ Sign Exclusive License for BFI-751—A Biosimilar to Stelara
The CuraTeQ-BioFactura licensing deal allows the parties to improve outcomes, quality of life, and the patient experience with high quality biosimilars. FREDERICK, MD, UNITED STATES, July 12, 2023 /EINPresswire.com/ -- BioFactura and CuraTeQ Sign …